Found a bug or want a feature? Verified reports earn free credits.
Log inSign up

Product & regulatory approvals

Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.

Window30 days90 days180 daysSizeAll sizesLarge capMid capSmall capProfitable only
SortMost recentBest 1-week reactionLargest first
87 companies · 182 filings in 90 days
CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
Neetu YoshiCastings & ForgingsUpdates- Capacity Cum Capability Approval from Rail Coach factory, Kapurthala10 Jun 2026Regulatory Product Approval+6.5% +11.5% +5.1%₹169656 Cr29.3vs 28.921.8%—
AvenuesaiFinancial Technology (Fintech)Receipt of In-Principle Approval by Avenues World FZ LLC, Step Down Subsidiary Company from Central Bank of the UAE for a Retail Payment Services - Category III License4 Jun 2026Regulatory Product Approval-1.4% +2.7% +21.2%₹15.255,326 Cr14.8vs 90.96.2%+26.7%
Jeena Sikho LifecareWellnessJeena Sikho Lifecare Limited Has Informed the Exchange About Receipt of NABH Accreditation for Bhopal Hospital.3 Jun 2026Regulatory Product Approval-10.1% -12.8% -19.7%₹5076,300 Cr26.652.2%+13.5%
Bliss GVS PharmaPharmaceuticalsBliss GVS Pharma Limited has informed the Exchange about Intimation of WHO-GMP Compliance of Manufacturing Facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).2 Jun 2026Regulatory Product Approval+4.0% +0.2% +15.6%₹5766,095 Cr51.7vs 28.515.1%+5.2%
WockhardtPharmaceuticalsPursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release - "Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam), a Novel Intravenous Antibiotic ....30 May 2026Regulatory Product Approval×4-2.6% -9.0% -2.8%₹1,88830,586 Cr68.2vs 28.53.4%+23.4%
Corona RemediesPharmaceuticalsCORONA Remedies Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release - Receipt of EU-GMP Certificate".28 May 2026Regulatory Product Approval×2+0.5% +5.7% +17.1%₹2,14713,132 Cr72.9vs 28.528.5%-2.2%
One Mobikwik SystemsFinancial Technology (Fintech)In-Principle authorisation to operate as a Payment Aggregator - Physical under the Payment and Settlement Systems Act, 2007 received from the Reserve Bank of India26 May 2026Regulatory Product Approval×3+4.6% +1.4% +4.6%₹1961,546 Cr90.9vs 90.9-11.2%+6.8%
Page 3 of 3Previous
How this list is built

A company appears when an NSE/BSE filing inside the last 90 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.